Zika virus alert in India as woman tests positive

INDIA – The World Health Organization has released a press statement warning of Zika virus outbreak in India after a 24-year old pregnant tested positive for the virus in Kerala state, south-west India. According to the WHO’s health officials, this is the first Zika case confirmed in Kerala. The infection was confirmed in a laboratory using Real Time Polymerase Chain Reaction (RT-PCR) testing in the National Institute of Virology (NIV) Pune. A pregnant 24-year-old woman was found to be infected with the mosquito-borne disease and was being treated at a…

Read More

Double jeopardy as teen vaping on the rise amid COVID-19 pandemic

USA – An estimated 2 million middle school and high school students used e-cigarettes in 2021, with 85% using flavored options, according to an FDA/CDC study. The study looked at current, (i.e., in the last 30 days) e-cigarette use, frequency of use, and use by device type, flavors, and usual brand. This NYTS, which ran from January 18 to May 21, 2021, was the first to be fully implemented during the COVID-19 pandemic. It was an online survey that was used to collect data, allowing eligible students in USA to…

Read More

Lyme disease relief as Valneva and Pfizer announce phase 2 vaccine candidate breakthrough

USA – Valneva, a specialty vaccine company, and Pfizer Inc. have announced additional positive Phase 2 results for Lyme disease vaccine candidate VLA15, including a booster response. Valneva and Pfizer had announced a collaboration for the development and commercialization of VLA15. With phase 2 trials breakthrough, the two companies are collaborating closely on the next development steps, with a Phase 3 trial planned for 2022. VLA15 is a multivalent protein subunit vaccine that targets Borrelia’s outer surface protein A (OspA) knocking the bacteria out before the tick can transmit them…

Read More

Diabetic adults over 40 more likely to be hospitalized than children

USA – Adults over the age of 40 with insulin dependent diabetes mellitus (type 1 diabetes) who have COVID-19 are seven times more likely to be hospitalized than children with the same respiratory problem. Adults, unlike children, experience varying degrees of respiratory symptoms, with older adults and those with diabetes remain highly susceptible of acute respiratory distress syndrome and death. In contrast, children with COVID-19 rarely develop severe respiratory symptoms and frequently remain asymptomatic. “People with diabetes are at higher risk for COVID-19-related complications, especially if they are over the…

Read More

India’s fight against COVID-19 receives boost from J&J’s single-shot vaccine

INDIA- India expects to receive its first doses of Johnson & Johnson COVID-19 vaccine filled and finished in the country by American drugmaker’s partner Biological E. Last month, India’s drug regulator granted emergency approval to the J&J vaccine, whether imported or locally filled and finished by J&J’s Indian partner, Biological E. The Asian nation could receive up to 43.5 million doses of the single-shot vaccine in October, which would be a significant step toward helping India meet its target of producing more than 300 million doses in the month. Based…

Read More

Centre for disease control and prevention calls for new tact to deal with threatening delta variant

US – The Centre for Disease Control and Prevention (CDC), believe that the war against COVID-19 has changed because of the highly contagious delta variant. CDC proposed the need for a clearer message regarding COVID-19 information, mandatory vaccines for health workers and a return to universal masking. The organization documented the detriment of the contagious delta variant which is dominant across the globe and is as contagious as chickenpox and far more contagious than the common cold or flu. According to the CDC, the Delta variant has mutations on the…

Read More

An estimated 1.5 million children have lost parents due to the pandemic

WORLD – A new joint global study led by the United States Centers for Disease Control and Prevention and published in the Lancet reveals that during the first 14 months of the COVID-19 pandemic, at least 1.5 million children lost a parent, custodial grandparent, or other caregiver due to COVID-19. The study published in a Lancet report used mortality and fertility data to model minimum estimates and rates of COVID-19-associated deaths of primary or secondary caregivers for children younger than 18 years in 21 countries. Based on the study, an…

Read More

GE Healthcare’s serena bright now in five major hospitals across the United States

US – GE Healthcare, a leading global medical technology and digital solutions innovator, has installed Serena Bright, the industry’s first contrast-guided biopsy solution, helping empower clinicians and patients in their fight against breast cancer, in five hospitals across the United States (US). The technology received U.S. Food and Drug Administration 510(k) clearance in May 2020, will allow patients to have their breast biopsy exams with contrast guidance using the same mammography equipment, in the same room, and with the same staff as the screening or diagnostic mammogram. Among others, Serena…

Read More

Genome sequencing labs growth trend witnessed globally as India launches second facility at the Institute of Liver and Biliary Services

WORLD – The Institute of liver and Biliary Services will now have the privilege to house a second genome sequencing facility in India after the Chief minister of India, Arvind Kejriwal inaugurated its launch. This facility alongside the other one launched at Lok Nayak Hospital will reduce India’s dependency on National Centre for Disease Control (NCDC) when it comes to testing of samples. ILBS facility will be able to sequence nearly all 30000 molecules of SARS CoV2 with the help of the latest machines called NextSeq and MiSeq that can…

Read More

US department of defense injects US$2.9M to Ischemix for its phase one trial of traumatic brain injury drug

US – Ischemix, a privately owned company focused on developing therapeutics for serious medical conditions, has received funding worth US$2.9M from the US department of defense (USDoD) to conduct its phase 1 study of a traumatic brain injury (TBI) drug. This fund was granted by US Army Medical Research and Development Command (USAMRDC), Combat Casualty Care Research Program (CCCRP) in collaboration with the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium. The funding is meant pay for a substantial portion of manufacturing and formulating additional supply of the…

Read More